Sodium Picosulfate
Brand names: Dulcolax Pico, Laxoberal, Picolax (with magnesium citrate)
Sodium picosulfate is a stimulant laxative used for constipation and, in higher-strength combination products, for bowel cleansing before colonoscopy or surgery.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
It is hydrolysed by colonic bacteria into an active form that stimulates the mucosa of the large bowel, increasing motility and water secretion.
Prescribing in practice
- Bowel-cleansing preparations carry a risk of fluid and electrolyte disturbance and dehydration, so maintain adequate hydration and use with caution in frail, elderly, or renally impaired patients.
- It is contraindicated in intestinal obstruction, ileus, severe inflammatory bowel disease, and toxic megacolon.
- Effect is typically seen within several hours, so timing of administration should account for the expected onset.
Monitoring
Monitor for signs of dehydration and electrolyte imbalance, particularly with bowel-cleansing regimens in at-risk patients.
Counselling the patient
- Drink plenty of clear fluids during bowel preparation to avoid dehydration.
- Expect loose, watery stools and stay near a toilet once the dose takes effect.
Evidence & guidelines
Stimulant laxatives such as sodium picosulfate are established agents for constipation and bowel preparation in UK practice.
Reference: BSG Bowel Preparation Guidelines; SPC Picolax; SPC Laxoberal; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- Corrected Sodium (Hyperglycaemia) · Electrolytes
- Hyponatraemia Cause Algorithm · Electrolyte Disorders
- MELD-Na Score · Liver Disease
- Harvey-Bradshaw Index for Crohn's Disease · Inflammatory Bowel Disease
- Mayo Score for Ulcerative Colitis Activity · Inflammatory Bowel Disease
- Rome IV Criteria for Irritable Bowel Syndrome · Functional GI
- Lower Gastrointestinal Bleed · BSG 2019; NICE NG141
- Variceal Upper GI Bleed · BSG 2015; Baveno VII (2022)
- Spontaneous Bacterial Peritonitis (SBP) · BSG / EASL 2018
- Hepatorenal Syndrome · EASL 2018; ICA 2015
- Hepatic Encephalopathy · EASL 2014; West Haven criteria
- Clostridioides difficile Colitis · NICE NG199 (2021); IDSA/SHEA 2021